NCT04305444 2025-01-08Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's LymphomasZhejiang DTRM BiopharmaPhase 2 Terminated55 enrolled
NCT00978432 2016-11-25Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Duke UniversityPhase 2 Terminated50 enrolled 11 charts